DiaMedica Therapeutics Inc. announced the appointment of Dominic Cundari as Chief Commercial Officer. In this role, Cundari will be focused primarily on the commercial planning, positioning and launch preparations for DM199 in acute ischemic stroke. Prior to joining DiaMedica, Cundari spent over twenty years launching innovative products and building and managing commercial organizations in multiple therapeutic areas at Genentech.

He was most recently Senior Director of Genentech's vascular franchise. Prior to this role, Cundari was Senior Director of Genentech's cardiovascular franchise and Director of Cardiovascular sales. Earlier in his career, Cundari held multiple senior sales leadership roles in diverse therapeutic areas for Genentech and Ciba-Geigy.